The European life science instrumentation market is projected to grow at a significant CAGR of around 6.1% during the forecast period. The significant growth in the healthcare infrastructure coupled presence of key biopharmaceutical companies such as GlaxoSmithKline and other major biopharmaceutical companies in Europe keeps it at a leading position in the global life science industry. The healthcare expenditure of Germany and Sweden comprises of a total 11.1% each of their total GDP. Similarly, France comprises 11% healthcare expenditure out of total GDP, followed by UK, Spain Italy, and other European countries. Healthcare expenditure plays a crucial role in the development of new technology and devices in the healthcare sector. As the spending in the R&D is rising, the healthcare sector is also estimated to increase, thereby promoting the growth of the life science instrumentation market during the forecast period.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/european-life-science-instrumentation-market
Moreover, Significant public funding in cell culture techniques and stem cell projects have been observed in the EU in the last decade that further encourages the demand for life science research coupled with significant adoption of life science instrumentation in the region. As per the German Stem Cell Network (GSCN) report, three economies of the region were successful in raising money for stem cell research cooperation projects within the EU health program 2007-2013. These economies include UK, Germany, and Sweden. Moreover, the report reveals that UK researchers were particularly successful in acquiring EU money, with $164 million raised. At the same time, German stem cell researchers received $161 million and Sweden $49 million.
Key questions addressed by the report
- What is the market growth rate during the forecast period?
- Which segment/region dominates the market in the base year?
- Which segment/region will project the fastest growth in the market during the forecast period?
- How will COVID-19 impact the market growth in 2020 and the coming years?
o Recovery Timeline
o Deviation fromthe pre-COVID forecast
o Most affected region/segment
o Recommendations
- Who is the leader in the market?
- How are players addressing challenges to sustain growth?
- Where is the investment opportunity?
European Life Science Instrumentation Market – Segmentation
By Technology
- Chromatography
- Spectroscopy
- Polymerase Chain Reaction (PCR)
- Clinical Chemistry Analyzers
- Immunoassays
- Next-Generation Sequencing (NGS)
- Flow Cytometry
- Microscopy
- Others (Centrifuges, Electrophoresis)
By End-User
- Pharmaceutical & Biotechnology Companies
- Research Institutes
- Hospitals and Laboratories
A full report of European Life Science Instrumentation Market is available at: https://www.omrglobal.com/industry-reports/european-life-science-instrumentation-market
European Life Science Instrumentation Market– Segment by Region
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Company Profiles
- Biomerieux S.A.
- Carl Zeiss AG
- Danaher Corp.
- Eppendorf AG
- General Electric Co.
- Illumina, Inc.
- Merck KGaA
- QIAGEN N.V.
- Thermo Fisher Scientific Inc.
- Tecan Trading AG
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
